About
His research interests include:
(a) Circadian biology, metabolism, and ageing
(b) Regulation, safety, and efficacy of functional foods and nutraceuticals
(c) Discerning the role of lipid mediators such as eicosanoids and platelet-activating factors in inflammatory diseases.
(d) The role of a patient's nutritional status and the use of supplements during COVID-19.
Check out the webpage for research, science communication and how to make contact.
Publications
Milk Polar lipids: Untapped Potential for Pharmaceuticals and Nutraceuticals
Aditi Pawar, I. Zabetakis, Tanvi Gavankar, R. Lordan
PharmaNutrition, 2023
Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs.
C. Skarke, R. Lordan, Kayla Barekat, A. Naik, D. Mathew, T. Ohtani, A. Greenplate, Gregory R Grant, N. Lahens, S. Gouma, Elizabeth Troisi, Arjun Sengupta, A. Weljie, Wenzhao Meng, E. L. Luning Prak, Kendall A. Lundgreen, Paul Bates, H. Meng, G. FitzGerald
Journal of Pharmacology and Experimental Therapeutics, 2023
The Circadian Biology of Heart Failure
Nadim El Jamal, R. Lordan, S. Teegarden, T. Grosser, G. FitzGerald
2023
Editorial: Phospholipids and sphingolipids in nutrition, metabolism, and health
R. Lordan, C. Blesso
Frontiers in Nutrition, 2023
Sexual dimorphism in the response to chronic circadian misalignment on a high-fat diet
S. Anderson, H. Meng, T. Brooks, S. Tang, R. Lordan, Arjun Sengupta, Soumyashant Nayak, Antonijo Mřela, Dimitra Sarantopoulou, N. Lahens, A. Weljie, Gregory R Grant, F. Bushman, G. FitzGerald
Science Translational Medicine, 2023
Shannon L Cox, James R. O’Siorain, Yan He, R. Lordan, A. Naik, S. Tang, Shaon Sengupta, G. FitzGerald, R. Carroll, Annie M. Curtis
The FASEB Journal, 2023
The Current Use and Evolving Landscape of Nutraceuticals
A. Chopra, R. Lordan, Olaf K. Horbańczuk, A. Atanasov, I. Chopra, J. Horbańczuk, A. Jóźwik, Linfang Huang, V. Pirgozliev, Maciej Banach, M. Battino, N. Arkells
Pharmacological Research, 2022
View all
Projects
Circadian Regulation of Metabolism and Aging
2020 - Present: This project aims to understand the role of circadian misalignment and its contribution to metabolic diseases and aging, with a focus on Bmal1.
Lipid Mediators of Inflammation
2016 - Present: Platelet-activating factor (PAF), prostaglandins, and leukotrienes play a pivotal role in inflammatory signaling. We are interested in the development of novel therapeutic agents targeting these inflammatory mediators.
COVID-19 Research and Review Consortium
2020 - 2021: COVID-19 Review Consortium at UPenn. Our aim is to distill the existing COVID-19 literature into reviews that document the most reliable research to date in the areas of pathogenesis, therapeutics, prophylactics, and diagnostics.
2018 - 2021: Heart Healthy Salmon Nutraceuticals
The aim of this project was to assess the antioxidant properties and elucidate the structures of antithrombotic polar lipids from farmed Atlantic salmon using C30RP-UHPLC-HRAM-MS/MS for the development of novel nutraceuticals.
Contact
Dr Ronan Lordan
Available to discuss new collaborations, science outreach or speaking opportunities. Feel free to make contact via email or twitter.
Institute for Translational Medicine and Therapeutics
Perelman School of Medicine, University of Pennsylvania
